Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under GYRE THERAPEUTICS, INC. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Yue Xiong, Director (Form 8-K filed 2026-07-16). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Songjiang Ma (filed 2026-05-07).
Who is behind it
Gyre Therapeutics, Inc.: incorporated in Delaware; business address in San Diego, California; industry Pharmaceutical Preparations (Form D, 2026-07-16).
Officers and directors, each with the role and the filing that names them:
- Charles Wu: Director, Executive Officer (Form D, 2023-11-13)
- Songjiang Ma: Director, Executive Officer (Form D, 2023-11-13)
- Ruoyu Chen: Executive Officer (Form D, 2023-11-13)
- Weiguo Yu: Executive Officer (Form D, 2023-11-13)
- Ying Luo: Director (Form D, 2023-11-13)
- Thomas Eastling: Director (Form D, 2023-11-13)
- Renate Parry: Director (Form D, 2023-11-13)
- Gordon G. Carmichael: Director (Form D, 2023-11-13)
- Han Ying: Director (Form D, 2023-11-13)
- Usman Nassim: Director (Form D, 2023-11-13)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-05-07 | Songjiang Ma | 6.33% |
| Schedule 13D/A, 2026-05-06 | Ying Luo | 8.6% |
| Schedule 13D/A, 2026-05-06 | Gni Group LTD. | 69.1% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-07-16 | Yue Xiong | Director | appointed | 2026-08-01 |
| Form 8-K, 2026-05-04 | Ying Luo | Chief Executive Officer | appointed | |
| Form 8-K, 2026-05-04 | Thomas Eastling | Chief Financial Officer | appointed | |
| Form 8-K, 2026-05-04 | Ying Luo | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2023-11-13 | $5M | $5M |
Latest IPO step: Gyre Therapeutics, Inc. withdrew its IPO registration (RW, 2024-07-12).
IPO filings: RW, 2024-07-12, RW, 2024-07-12.
Acquisitions reported on Form 8-K, Item 2.01: acquired Cullgen Inc. (2026-05-04).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/gyre-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13D/A, 2026-05-07 · Form D, 2023-11-13 · Form 8-K, 2026-07-16 · Form 8-K, 2026-05-04
Who owns Gyre Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/gyre-therapeutics